| Erythrocyte Function and Pathophysiology | Lifetime | 31 | US 20 | 99.47 |
| Blood transfusion and management | Lifetime | 13 | US 5 | 99.41 |
| Neonatal Health and Biochemistry | Lifetime | 56 | US 30 | 99.01 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 96 | US 44 | 99.12 |
| Blood groups and transfusion | Lifetime | 78 | US 34 | 99.05 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 390 | US 190 | 98.87 |
| Hemoglobin structure and function | Lifetime | 144 | US 85 | 98.15 |
| Hemoglobinopathies and Related Disorders | Lifetime | 436 | US 219 | 97.66 |
| Blood properties and coagulation | Lifetime | 409 | US 204 | 96.31 |
| Histone Deacetylase Inhibitors Research | Lifetime | 557 | US 270 | 95.17 |
| Erythropoietin and Anemia Treatment | Lifetime | 458 | US 189 | 93.75 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 593 | US 288 | 94.19 |
| High Altitude and Hypoxia | Lifetime | 711 | US 275 | 92.92 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 1 | US 1 | 99.56 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 1 | US 1 | 99.88 |
| Neonatal Health and Biochemistry | 2021-2025 | 1 | US 1 | 99.81 |
| Epigenetics and DNA Methylation | 2021-2025 | 25 | US 13 | 99.03 |
| Blood transfusion and management | 2021-2025 | 5 | US 2 | 98.88 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 32 | US 10 | 98.27 |
| Blood groups and transfusion | 2021-2025 | 13 | US 3 | 99.13 |
| Hemoglobin structure and function | 2021-2025 | 3 | US 2 | 96.73 |
| Metabolism and Genetic Disorders | 2021-2025 | 47 | US 9 | 96.74 |
| Folate and B Vitamins Research | 2021-2025 | 57 | US 14 | 92.58 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 257 | US 67 | 93.94 |
| Blood properties and coagulation | 2021-2025 | 32 | US 11 | 94.40 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 53 | US 16 | 91.98 |
| Adipose Tissue and Metabolism | 2021-2025 | 426 | US 117 | 92.07 |
| Acute Myeloid Leukemia Research | 2021-2025 | 670 | US 304 | 94.34 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 159 | US 74 | 91.18 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 103 | US 34 | 89.41 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 519 | US 155 | 82.77 |
| Muscle metabolism and nutrition | 2021-2025 | 648 | US 121 | 83.47 |
| Drug Transport and Resistance Mechanisms | 2021-2025 | 727 | US 169 | 76.90 |
| Blood donation and transfusion practices | 2021-2025 | 334 | US 99 | 75.74 |
| Exercise and Physiological Responses | 2021-2025 | 908 | US 150 | 75.08 |
| Immune responses and vaccinations | 2021-2025 | 828 | US 236 | 58.96 |
| Amino Acid Enzymes and Metabolism | 2021-2025 | 936 | US 160 | 54.62 |
| Polyamine Metabolism and Applications | 2021-2025 | 936 | US 87 | 47.58 |
| Hydrogen's biological and therapeutic effects | 2021-2025 | 644 | US 33 | 31.56 |
| Methemoglobinemia and Tumor Lysis Syndrome | 2021-2025 | 212 | US 53 | 30.98 |
